TravisJSalvesenGS. Human plasma proteinase inhibitors. Ann Rev Biochem1983; 52: 655–709
4.
CoxDW. α1-Antitrypsin deficiency. In: ScriverCBeaudetASlyWValleD, eds. The Metabolic Basis of Inherited Disease, 6th edn.McGraw Hill, Maidenhead: 1989: 2409–38
5.
CrystalR. α 1-Antitrypsin deficiency, emphysema. and liver disease. Genetic basis and strategies for therapy. J Clin Invest1990; 85: 1343–52
6.
SifcrsRNFinegoldMJWooSL. Molecular biology and genetics of alpha 1-antitrypsin deficiency. Sent Liver Dis1992; 12: 301–10
7.
LomasDACarrellRW. A protein structural approach to the solution of biological problems: α 1-antitrypsin as a recent example. Am J Phvs1993; 265: L211–L219
8.
LoebermanHTokuokaRDiesenhoferJHuberR. Human α1-proteinase inhibitor. Crystal structure analysis of two crystal modifications; molecular model and preliminary analysis of the implications for function. J Molec Biol1984; 177: 531–56
9.
WuYForemanRC. The molecular genetics of α1 antitrypsin deficiency. BioEssavs1991; 13: 163–8
10.
PotempaJKorzusETravisJ. The serpin superfamily of proteinase inhibitors: Structure, function and regulation. J Biol Chem1994; 269: 15957–60
11.
BillingsleyGDWalterMAHammondGLCoxDW. Physical mapping of four serpin genes: α1-antitrypsin, α1-antichyrnotrypsin, corticostcroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome 14q32.1. Am J Hum Genet1993: 52: 343–53
12.
PerlinoECorteseRCilibertoG. The human α1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes. EMBO J1987; 6: 2767–71
13.
PerlmutterDHTravisJPunsalPI. Elastase regulates the synthesis of its inhibitor, α1-prolcinase inhibitor, and exaggerates the defect in homozygous PiZZ α1-proteinase deficiency. J Clin Invest1988; 81: 1744–80
14.
FaberJ-PPollerWWeidingerSKirchgesserMSchwaabRBidlingmaierF. Identification and DNA sequence analysis of 15 new α1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele. Am J Hum Genet1994; 55: 1113–21
15.
CoxDWJohnsonAMFagerholMK. Report of nomenclature meeting for αl-antitrypsin. Hum Genet1980; 53: 429–33
16.
FagerholMKCoxDW. The Pi polymorphism. Genetic, biochemical, and clinical aspects of human α1-antitrypsin. In: HarrisHHirschornK, eds. Advances in Human Genetics.New York: Plenum Press.1981
17.
BrantlyMNukiwaTCrystalRG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med1988; 83(suppl 6A): 13–31
18.
LomasDEvansDFinchJCarrellR. The mechanism of Z α1-antitrypsin accumulation in the liver. Nature1992; 357: 605–7
19.
OgushiFFellsGAHubbardSDStrausSDCrystalRG. Z-type α1-antitrypsin as an inhibitor of neutrophil elastase. J Clin Invest1987; 80: 1366–74
20.
LongGLChandraTWooSLCDavieEWKurachiK. Complete sequence of the cDNA for human α1-antitrypsin and the gene for the S variant. Biochemistry1984; 23: 4828–37
21.
OwenMCBrennanSOLewisJHCarrellRW. Mutation of antitrypsin to antithrombin. α1-antitrypsin Pittsburgh (358 Met→Arg), a fatal bleeding disorder. N Engl J Med1983; 309: 694–8
22.
VidaudDEmmerichJAlhenc-GelasMYvartJFiessengerJNAiachM. Met 358 to Arg mutation of alpha1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency. J Clin Invest1992; 89: 1537–43
23.
BythBCBillingsleyGDCoxDW. Physical and genetic mapping of the serpin gene cluster at 14q32.1: Alleleic association and a unique haplotype associated with α1-antitrypsin deficiency. Am J Hum Genet1994; 55: 126–33
24.
ErikssonS. Studies in α1-antitrypsin deficiency. Acta Med Scand1965; 177 (suppl 432): 1–85
25.
KueppersFBlackLF. α1-antitrypsin and its deficiency. Am Rev Respir Dis1974; 110: 176–94
26.
TobinMJCookPJLHutchisonDCS. Alpha1-antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z: A survey by the British Thoracic Association. Br J Dis Chest1984; 77: 14–27
27.
WallMMoeEEisenbergJPowersMBuistNBuistAS. Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency. J Pediatr1990; 116: 248–51
28.
LarssonC. Natural history and life expectancy in severe alpha1-antitrypsin, PiZ. Acta Med Scand1978; 204: 345
29.
GishenPSaundersAJSTobinMJHutchisonDCS. Alpha1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ. Clin Radiol33: 371–7
30.
ThurlbeckWMHendersonJAFraserRGBatesDV. Chronic obstructive lung disease: A comparison between clinical, roentgenologic, functional and morphologic criteria in chronic bronchitis, emphysema, asthma and bronchiectasis. Medicine (Balt)1970; 49: 81
31.
TalamoRCLangleyCEReedCEMakinoS. α1-antitrypsin deficiency: a variant with no detectable (α1-antitrypsin. Science1973; 181: 70–1
32.
HutchisonDCSTobinMJCookPJL. Alpha, antitrypsin deficiency: Clinical and physiological features in heterozygotes of Pi type SZ. A survey by the British Thoracic Association. Br J Dis Chest1983; 77: 28–34
33.
MittmanC. The PiMZ phenotype: Is it a significant risk factor for the development of chronic obstructive lung disease?Am Rev Respir Dis1978; 118: 649–52
34.
SniderGL. Emphysema: The first two centuries—and beyond. Ann Rev Respir Dis1992; 146: 1334–-44 (Part 1), 1615–22 (Part 2)
35.
HoidalJRNiewohnerDE. Cigarette smoke inhalation potentiates elastase-induced emphysema in hamsters. Am Rev Respir Dis1983; 127: 478–81
36.
AbboudRTFeraTRichterATabonaMZJohalS. Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid. Am Rev Resp Dis1985; 131: 79–85
37.
TrivediPMieli-VerganiGMowatAP. Paediatric Cholestasis: An overview. In: LentzeMReichenJ, eds. Pediatric Cholestasis: Novel Approaches To Treatment.London: Kluwer Academic Publishers, 1992: 129–38
38.
ErikssonSCarlsonJ, Alpha1-antitrypsin deficiency and related disorders. In: McIntyreNBenhamouJ-PBircherJRizzettoMRodesJ, eds. Oxford Textbook of Clinical Hepatology.Oxford: Oxford University Press, 1991: 958–66
39.
ErikssonSCarlsonJVelezR. Risk of cirrhosis and primary liver cancer in alpha-1-antitrypsin deficiency. N Engl J Med1986; 314: 736–9
40.
HussainMMieli-VerganiGMowatAP. Alpha-1-antitrypsin Deficiency and Liver Disease: Clinical presentation, diagnosis and treatment. J Inher Metabol Dis1991; 14: 497–511
41.
KellyCPTyrellDNMMcDonaldGSAWhite-HouseDBPrichardJS. Heterozygous FZ alpha-1-antitrypsin deficiency associated with severe emphysema and hepatic disease: Case report and family study. Thorax1989; 44: 758–9
42.
PoveyS. Genetics of α1-antitrypsin deficiency in relation to neonatal liver disease. Molec Biol Med1990; 7: 161–72
43.
SvegerT. The natural history of liver disease in α1-antitrypsin deficient children. Acta Paediatr Scand1988; 77: 847–51
44.
ReadCLWienerCJCoxDWRichterJEGeisingerKR. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha-1-antitrypsin. Gastroenterology1987; 93: 181–7
45.
PsacharopoulosHTMowatAPCookePJLCarlilePAPortmannBRodeckCH. Outcome of liver disease associated with alpha-1 antitrypsin deficiency. Implications for genetic counselling and antenatal diagnosis. Arch Dis Childh1983; 58: 882–7
46.
MondelliMMieli-VerganiGEddlestonALWFWilliamsRMowatAP. Lymphocyte cytotoxicity to autologous hepatocytes in alpha-1-antitrypsin deficiency. Gut1984; 25: 1044–9
47.
DohertyDGDonaldsonPTWhitehouseDBMieli-VerganiGDuthieAHopkinsonDA. HLA phenotypes and gene polymorphisms in juvenile liver disease associated with alpha-1-antitrypsin deficiency. Hepatology1990; 12: 218–23
48.
WuYWhitmanIMolmentiEMooreKHippenmeyerPPerlmutterDH. A lag in intracellular degradation of mutant α1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ α1-antitrypsin deficiency. Proc Nat Acad Sci USA1994; 91: 9014–8
49.
LabrunePOdievreMAlagilleD. Influence of sex and breastfeeding on liver disease in alpha-1-antitrypsin deficiency. Hepatology1989; 10: 122
50.
LomasDAFinchJTSeyamaKNukiwaTCarrellRW. α1-Antitrypsin Siiyama (Ser53→Phe). Further evidence for intracellular loop-sheet polymerization. J Biol Chem1993; 268: 15333–5
51.
CurielDTHolmesMDOkayamaHBrantlyMVogelmeirGTravisW. Molecular basis of the liver and lung disease associated with alpha 1-antitrypsin deficiency allele Mmalton. J Biol Chem1989; 264: 13938–5
52.
CarlsonJARogersBBSifersRNFinegoldMJCliftSMDeMayoFJ, at al. Accumulation of PIZ alpha-1-antitrypsin causes liver damage in transgenic mice. J Clin Invest1989; 83: 1183–90
53.
MavierPPreauxA-MGuigulBLescsM-CZafaraniE-SDhumeauxD. In vitro toxicity of polymorphonuclear neutrophils to hepatocytes: Evidence for a proteinase-mediated mechanism. Hepatology1988; 8: 254–6
54.
RuoslahtiEPierschbacherMD. Molecular Basis of Cell-Extracellular Matrix interactions. In: AriasIMJakobyWPPopperHSchachterDShafritzDA, eds. The Liver Biology and Pathobiology, 2nd edn.New York: Raven Press, 1987: 739–45
55.
UdallINDixonMNewmanAPWrightJAJamesBBlochKI. Liver disease in alpha-1 antitrypsin deficiency. A retrospective analysis of the influence of early breast versus bottle feeding. J Am Med Assoc1985; 253: 2679–82
56.
WewersMDGadeckJEKeoghBAFellsGACrystalRG. Evaluation of danazol therapy for patients with PiZZ alpha-1-antitrypsin deficiency. Am Rev Resp Dis1986; 134: 487–80
57.
KaiserLRCooperJDTrulockEPasqueMKTriantafillouAHaydockD. The evolution of single lung transplantation for emphysema. J Thorac Cardiovasc Surg1991; 102: 333–41
58.
BernoufTConstansJClercADescampsJMartinacheLGoudemandM. Biochemical and biological properties of an α1-antitrypsin concentrate. Vox Sang1987; 52: 291–7
59.
FournelMANewgrenJOBetancourtCMIrwinRG. Preclinical evaluation of alpha-1-proteinase inhibitor: Pharmacokinetics and safety studies. Am J Med1988; 84 (suppl 6A): 43–7
60.
CarlesPConstansJPujazonMCArnaudJLanqueDGoudemandM. Bilan à deux du traitement substitutif de l'emphysème Pi ZZ par l'alpha-1-antitrypsine. Presse Med1990; 19: 514–8
61.
WewersMDCasolaroMASellersSESwayzeSCMcPhaulKMWittesJT. Replacement therapy for alpha1-antitrypsin deficiency associated with emphysema. N Engl J Med316: 1055–62
62.
HubbardSCSellarsSECzerskiDStephensLCrystalRG. Biochemical efficacy and safety of monthly augmentation therapy for a1-antitrypsin deficiency. J Am Med Ass1988; 260: 1259–64
63.
DirksenAMadsenFUlrikCSKok-JensenAHeckscherTViskumK, A randomized placebo-controlled study of alpha-1-protease inhibitor therapy monitored by daily spirometry. Am Rev Resp Dis1993; 147 (suppl): A325
64.
CherfasJ. Sheep to produce α1-antitrypsin. BMJ1992; 304: 527
65.
RosenbergSBarrPJNajarianRCHallewellRA. Synthesis in yeast of a functional oxidation-resistant mutant of human α1-antitrypsin. Nature1984; 312: 77–80
66.
CasolaroMAFellsGWewersMPierceJEOgushiFHubbardR. Augmentation of lung antineutrophil elastase capacity with recombinant human α-1-antitrypsin. J Appl Physiol1987; 63: 2015–23
67.
HubbardRCCasolaroMAMitchellMSellersSEArabiaFMatthayMA. Fate of aerosolized recombinant DNA-produced α1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance. Proc Natl Acad Sci1989; 86: 680–4
68.
SchnebliHP. Recombinant elastase inhibitors for therapy. Ann NY Acad Sci1991; 624: 212–8
69.
DaviesPAsheBMBonneyRJDornCFinkePFletcherD. The discovery and biological properties of cephalosporin-based inhibitors of PMN elastase. Ann NY Acad Sci1991; 624: 219–29
70.
PowersJCKaraCMHoriHOleksyszynJMeyerEF. Synthetic mechanism-based and transition-state inhibitors for human neutrophil elastase. In: GrassiCTravisJCasaliLLuisettiM, eds. Biochemistry of Pulmonary Emphysema.Surrey: Springer-Verlag, 1992
KayMABaleyPRothenbergSLelandFFlemingLPonderK. Expression of human α1-antitrypsin in dogs after autologus transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci1992; 89: 89–93
73.
RosenfeldMASiegfriedWYoshimuraKFukayamaMStierME. Adenovirus mediated transfer of a recombinant α1-antitrypsin gene to the lung epitheliumin vivo. Science1991; 252: 431–4
CrystalRG. Gene therapy strategies for pulmonary disease. Am J Med1992; 92 (suppl 6A): 44S–52S
76.
BuisseretPDPembreyMELessofMH. α1-Antitrypsin phenotypes in rheumatoid arthritis and ankylosing spondylitis. Lancet1977; ii: 1358–9
77.
SteersGMcMahonMJGrennanDMHillarbyMC. Lack of association of the alpha-1-antitrypsin PIZ allele with rheumatoid arthritis or with its extra articular complications. Dis Markers1992; 10: 151–7
78.
StrifeCFHugGChuckGMcAdamsAJDavisCAKlineJJ. Membranoproliferative glomerulonephritis and α1-antitrypsin deficiency in children. Pediatrics1983; 71: 88–92
79.
WhicherJRitchieRJohnsonMyron ABaudnerSBienvenuJBlirup-JensenS. New International Reference Preparation for Proteins in Human Serum (RPPHS). Clin Chem1994; 40: 934–8
80.
JeppsonJ-OFranzenB. Typing of genetic variants of a, antitrypsin by electrofocusing. Clin Chem1982; 28: 219–25
81.
JeppssonJ-OEinarssonR. Genetic variants of α1-Antitrypsin and Hemoglobin Typed by Isoelectric Focusing in Preselected Narrow pH Gradients with PhastSystem. Clin Chem1992; 38: 577–80
82.
WeidingerSJahnWCujnikFSchwarzfischerF. Alpha-1-antitrypsin: Evidence for a fifth PI M subtype and a new deficiency allele PI*ZAusburg. Hum Genet1985; 71: 27–9
83.
WeidingerS. Reliable phenotyping of alpha-1-antitrypsin by hybrid isoelectric focusing in an ultranarrow immobilised pH gradient. Electrophoresis1992; 13: 234–9
84.
WhitehouseDBLovegroveJUHopkinsonDA. Variation in alpha-1-antitrypsin phenotypes associated with penicillamine therapy. Clin Chim Acta1989; 179: 109–16
85.
WhitehouseDBLovegroveJUMieli-VerganiGMowatAPHopkinsonDA. ‘SZ like’ α1-antitrypsin phenotypes in PI ZZ children with liver disease. Ann Hum Gen1994; 58: 11–7
86.
WallmarkAAlmRErikssonS. Monoclonal antibody specific for the mutant PiZ α1-antitrypsin and its application in an ELISA procedure for identification of PiZ gene carriers. Proc Natl Acad Sci1984; 81: 5690–3
87.
ZegersNDClaasenEGerritseKDeenCBoersmaW. Detection of genetic variants of α1-antitrypsin with site-specific monoclonal antibodies. Clin Chem1991; 37: 1606–11
88.
KiddVJWallaceRBItakuraKWooSLC. αl-Antitrypsin deficiency detection by direct analysis of the mutation in the gene. Nature1983; 304: 230–4
89.
AbbottCMLovegroveJUWhitehouseDBHopkinsonDAPoveyS. Prenatal diagnosis of alpha-1-antitrypsin deficiency by PCR of linked polymorphisms: A study of 17 cases. Prenatal Diagnosis1992; 12: 235–40
90.
TazelaarJPFriedmanKJKlineRSGuthrieMLFarberRA. Detection of α1-antitrypsin Z and S mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin Chem1992; 38: 1486–8
91.
AndresenBSKnudsenIJensenPKARasmussenKGregersenN. Two novel nonradioactive polymerase chain reaction-based assays of dried blood spots, genomic DNA, or whole cells for fast, reliable detection of Z and S mutations in the α1-antitrypsin gene. Clin Chem1992; 38: 2100–7
92.
NewtonCRGrahamAHeptinstallLEPowellSJSummersCKalshekerN. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res1898; 17: 2503–15
93.
LloydCTravisJ. Rapid Screening for Deficiency of α1-Proteinase Inhibitor. Clin Chem1989; 35: 1971–5
94.
Bruun-PetersenKBruun-PetersenGDahlRLarsenBKølvraaSKochJ. Alpha,-antitrypsin alleles in patients with pulmonary emphysema, detected by DNA amplification (PCR) and oligonucleotide probes. Eur Respir J1992; 5: 531–7
95.
SvegerT. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med1976; 294: 1316–21
96.
McNeilTFSvegerTThelinT. Psychosocial effects of screening for somatic risk: The Swedish α1 antitrypsin experience. Thorax1988; 43: 505–7